{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:35:36Z","timestamp":1793378136622,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002382","name":"King Faisal Specialist Hospital & Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002382","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.rmed.2026.109051","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T06:55:55Z","timestamp":1784876155000},"page":"109051","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Phenotypic patterns and outcomes of connective tissue disease-associated pulmonary arterial hypertension: a Saudi single center experience"],"prefix":"10.1016","volume":"261","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5354-0850","authenticated-orcid":false,"given":"Noura","family":"Alturaif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0593-9538","authenticated-orcid":false,"given":"Saleh","family":"Alhammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fayez","family":"Alahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeen","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamdeia","family":"Zaytoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanadi","family":"Alhamoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Alzubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah M.","family":"Aldalaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima K.","family":"Alduraibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2026.109051_bib1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00296-025-05845-z","article-title":"Prevalence, molecular mechanisms and diagnostic approaches to pulmonary arterial hypertension in connective tissue diseases","volume":"45","author":"Grygiel-G\u00f3rniak","year":"2025","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.rmed.2026.109051_bib2","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1007\/s10067-022-06446-y","article-title":"Pulmonary hypertension in connective tissue diseases: epidemiology, pathogenesis, and treatment","volume":"42","author":"Cansu","year":"2023","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.rmed.2026.109051_bib3","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1378\/chest.10-0260","article-title":"Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype","volume":"138","author":"Chung","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2026.109051_bib4","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1378\/chest.13-3014","article-title":"Unique predictors of mortality in patients with pulmonary arterial hypertension associated with systemic sclerosis in the REVEAL registry","volume":"146","author":"Chung","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2026.109051_bib5","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/rheumatology\/kead360","article-title":"Treatment strategies and survival of patients with connective tissue disease and pulmonary arterial hypertension: a COMPERA analysis","volume":"63","author":"Distler","year":"2024","journal-title":"Rheumatology"},{"key":"10.1016\/j.rmed.2026.109051_bib6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1183\/09059180.00003811","article-title":"Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus","volume":"20","author":"Johnson","year":"2011","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.rmed.2026.109051_bib7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1164\/rccm.200806-953OC","article-title":"Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era","volume":"179","author":"Condliffe","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2026.109051_bib8","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3390\/diagnostics11050911","article-title":"Systemic sclerosis-associated pulmonary hypertension: spectrum and impact","volume":"11","author":"Naranjo","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.rmed.2026.109051_bib9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.rmed.2017.11.020","article-title":"Pulmonary arterial hypertension in the setting of scleroderma is different than in the setting of lupus: a review","volume":"134","author":"Bazan","year":"2018","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2026.109051_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103514","article-title":"Idiopathic and connective tissue disease-associated pulmonary arterial hypertension (PAH): similarities, differences and the role of autoimmunity","volume":"23","author":"Favoino","year":"2024","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.rmed.2026.109051_bib11","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1164\/rccm.201507-1456OC","article-title":"Comparison of treatment response in idiopathic and connective tissue disease-associated pulmonary arterial hypertension","volume":"192","author":"Rhee","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2026.109051_bib12","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/art.41669","article-title":"Long-term outcomes in patients with connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era: meta-analyses of randomized, controlled trials and observational registries","volume":"73","author":"Khanna","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.rmed.2026.109051_bib13","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jama.2022.4402","article-title":"Diagnosis and treatment of pulmonary arterial hypertension: a review","volume":"327","author":"Ruopp","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.rmed.2026.109051_bib14","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ijcard.2017.01.097","article-title":"Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: a cohort study in China","volume":"236","author":"Zhao","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.rmed.2026.109051_bib15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/rai2.12086","article-title":"Targeted treatment strategy for patients with severe pulmonary hypertension secondary to connective tissue diseases","volume":"3","author":"Jiang","year":"2023","journal-title":"Rheumatol Autoimmun"},{"key":"10.1016\/j.rmed.2026.109051_bib16","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.healun.2024.08.019","article-title":"Changes in REVEAL Lite 2 risk status are associated with long-term outcomes in patients with pulmonary arterial hypertension: a post-hoc analysis of the GRIPHON study","volume":"43","author":"Benza","year":"2024","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.rmed.2026.109051_bib17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijcard.2021.03.034","article-title":"Application of the REVEAL risk score calculator 2.0 in the PATENT study","volume":"332","author":"Benza","year":"2021","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.rmed.2026.109051_bib18","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.healun.2019.12.013","article-title":"Risk assessment in pulmonary arterial hypertension: insights from the GRIPHON study","volume":"39","author":"Sitbon","year":"2020","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.rmed.2026.109051_bib19","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.rmed.2026.109051_bib20","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/art.40320","article-title":"European league against rheumatism\/American college of rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"69","author":"Lundberg","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.rmed.2026.109051_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","article-title":"American college of rheumatology\/European league against rheumatism classification criteria for primary Sj\u00f6gren'S syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"69","author":"Shiboski","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.rmed.2026.109051_bib22","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"Classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.rmed.2026.109051_bib23","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"European league against rheumatism\/American college of rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.rmed.2026.109051_bib24","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(23)01525-8","article-title":"Rheumatoid arthritis","volume":"402","author":"Di Matteo","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2026.109051_bib25","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/joim.13752","article-title":"Clinical presentation, course, and prognosis of patients with mixed connective tissue disease: a multicenter retrospective cohort","volume":"295","author":"Chevalier","year":"2024","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.rmed.2026.109051_bib26","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1378\/chest.10-0260","article-title":"Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype","volume":"138","author":"Chung","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2026.109051_bib27","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1378\/chest.11-1460","article-title":"An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL registry","volume":"142","author":"Benza","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2026.109051_bib28","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/ajrccm\/aamaf003","article-title":"Study of risk assessment scores as surrogate endpoints in pulmonary arterial hypertension trials","volume":"212","author":"Liu","year":"2026","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2026.109051_bib29","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1177\/0961203314527366","article-title":"Chinese SLE Treatment and Research group (CSTAR) registry: II. Prevalence and risk factors of pulmonary arterial hypertension in Chinese patients with systemic lupus erythematosus","volume":"23","author":"Li","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.rmed.2026.109051_bib30","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00296-011-1880-4","article-title":"Clinical features and independent predictors of pulmonary arterial hypertension in systemic lupus erythematosus","volume":"32","author":"Lian","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.rmed.2026.109051_bib31","article-title":"Risk factors of systemic lupus erythematosus patients with pulmonary arterial hypertension: a systematic review and meta-analysis","volume":"102","author":"Lun","year":"2023","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.rmed.2026.109051_bib32","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1177\/0961203317702255","article-title":"Serological biomarkers as risk factors of SLE-associated pulmonary arterial hypertension: a systematic review and meta-analysis","volume":"26","author":"Wang","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.rmed.2026.109051_bib33","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.chest.2017.08.014","article-title":"Pulmonary arterial hypertension associated with systemic lupus erythematosus: results from the french pulmonary hypertension registry","volume":"153","author":"Hachulla","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2026.109051_bib34","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/art.39432","article-title":"Characteristics and survival of anti-U1 RNP antibody-positive patients with connective tissue disease-associated pulmonary arterial hypertension","volume":"68","author":"Sobanski","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.rmed.2026.109051_bib35","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3892\/etm.2021.10357","article-title":"Clinical characteristics and survival of patients with three major connective tissue diseases associated with pulmonary hypertension: a study from China","volume":"22","author":"Pan","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.rmed.2026.109051_bib36","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1183\/09031936.00182813","article-title":"Connective tissue disease-associated pulmonary arterial hypertension in Chinese patients","volume":"44","author":"Hao","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2026.109051_bib37","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1007\/s12325-025-03389-z","article-title":"Immunosuppressive therapy for pulmonary arterial hypertension associated with connective tissue diseases: insights from Japanese registry","volume":"42","author":"Tamura","year":"2025","journal-title":"Adv. Ther."},{"key":"10.1016\/j.rmed.2026.109051_bib38","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1093\/rheumatology\/kes140","article-title":"Clinical characteristics and survival of Japanese patients with connective tissue disease and pulmonary arterial hypertension: a single-centre cohort","volume":"51","author":"Shirai","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.rmed.2026.109051_bib39","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1093\/rheumatology\/kead103","article-title":"10-year survival of pulmonary arterial hypertension associated with connective tissue disease: insights from a multicentre PAH registry","volume":"62","author":"Chen","year":"2023","journal-title":"Rheumatology"},{"key":"10.1016\/j.rmed.2026.109051_bib40","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/rheumatology\/kev097","article-title":"Pulmonary arterial hypertension in systemic lupus erythematosus may benefit by addition of immunosuppression to vasodilator therapy: an observational study","volume":"54","author":"Kommireddy","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.rmed.2026.109051_bib41","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1378\/chest.130.1.182","article-title":"Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension","volume":"130","author":"Sanchez","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2026.109051_bib42","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/1756-185X.14368","article-title":"Immunosuppressive therapy in patients with connective tissue disease-associated pulmonary arterial hypertension: a systematic review","volume":"25","author":"Ding","year":"2022","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.rmed.2026.109051_bib43","first-page":"282","article-title":"Pulmonary hypertension in systemic lupus erythematosus: evaluation of clinical characteristics and response to immunosuppressive treatment","volume":"29","author":"Tanaka","year":"2002","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.rmed.2026.109051_bib44","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1253\/circj.CJ-17-0351","article-title":"Predictors of favorable responses to immunosuppressive treatment in pulmonary arterial hypertension associated with connective tissue disease","volume":"82","author":"Yasuoka","year":"2018","journal-title":"Circ. J."},{"key":"10.1016\/j.rmed.2026.109051_bib45","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/art.23303","article-title":"Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases","volume":"58","author":"Jais","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.rmed.2026.109051_bib46","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1253\/circj.CJ-11-0473","article-title":"Intensive immunosuppressive therapy improves pulmonary hemodynamics and long-term prognosis in patients with pulmonary arterial hypertension associated with connective tissue disease","volume":"75","author":"Miyamichi-Yamamoto","year":"2011","journal-title":"Circ. J."},{"key":"10.1016\/j.rmed.2026.109051_bib47","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/S0735-1097(24)04082-8","article-title":"The effectiveness of immunosuppressive therapy in patients with pulmonary arterial hypertension associated with connective tissue diseases: data from national pulmonary hypertension registry in Japan","volume":"83","author":"Tamura","year":"2024","journal-title":"JACC (J. Am. Coll. Cardiol.)"},{"key":"10.1016\/j.rmed.2026.109051_bib48","doi-asserted-by":"crossref","DOI":"10.1177\/17534666251385674","article-title":"CTD-PAH: an updated practical approach to screening, diagnosis, and management","volume":"19","author":"Alturaif","year":"2025","journal-title":"Ther. Adv. Respir. Dis."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126004191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126004191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:42:48Z","timestamp":1793374968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611126004191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":48,"alternative-id":["S0954611126004191"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2026.109051","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenotypic patterns and outcomes of connective tissue disease-associated pulmonary arterial hypertension: a Saudi single center experience","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2026.109051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109051"}}